Skip to content
Sola Diagnostics GmbH logo โ€” The WIDยฎ-easy Test - Now also available in Switzerland ๐Ÿ‡จ๐Ÿ‡ญ
๐Ÿ‘‰...

Sola Diagnostics GmbH

The WIDยฎ-easy Test - Now also available in Switzerland ๐Ÿ‡จ๐Ÿ‡ญ ๐Ÿ‘‰ Unnecessary hysteroscopy and curettage can be avoided

Founded 2020 Austria Austria 2 employees Seed Total: $2.39M Biotechnology, Health Care

General Information

Company Name Sola Diagnostics GmbH
Founded Year 2020
Location Austria Austria
Employees 2
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Sola Diagnostics GmbH. To contact Sola Diagnostics GmbH, visit sola-diagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sola Diagnostics GmbH compare?

A PDF of Sola Diagnostics GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sola Diagnostics GmbH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sola Diagnostics GmbH

Sola Diagnostics GmbH is a biotechnology and healthcare startup which is the home of the WIDยฎ-Test. Founded in 2020 and headquartered in Austria, the company has recently secured a โ‚ฌ400.00K Seed Round investment from FPS-Holding on 20 February 2025. Their slogan "The WIDยฎ-easy Test - Now also available in Switzerland" highlights the expansion of their innovative product, emphasizing its potential to prevent unnecessary hysteroscopy and curettage. This recent investment reflects investor confidence in Sola Diagnostics GmbH's vision and the promising future of their groundbreaking diagnostic technology.

Business keywords: women's health diagnostics, epigenetic testing, gynecological diagnostics, DNA methylation, PCR-based analysis, clinical validation, first-line diagnostic, non-invasive testing, cancer detection, startup expansion, private equity investment

Services & Products

Developing and providing epigenetic diagnostic tests for gynecological cancer detection

Target Customers

Patients healthcare providers and laboratories

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round โ‚ฌ400.00K 1
FPS-Holding
20 Feb 2025
Seed Round โ‚ฌ400.00K 1
FPS-Holding
24 Jun 2024
Seed Round โ‚ฌ1.36M -
11 Mar 2022
Pre Seed Round โ‚ฌ200.00K -
30 Sep 2021
Pre Seed Round โ‚ฌ35.00K -
29 May 2020

Sola Diagnostics GmbH Alternatives & Competitors

View All Alternatives
Sola Diagnostics GmbH vs
Antegenes
Antegenes Estonia

Innovative genetic tests for cancer risks with recommendations for prevention and early detection.

Seed
16 employees
Biotechnology, Health Care
Sola Diagnostics GmbH vs

We are reinventing the way people around the world access genetic expertise. Clear Genetic is deve...

Venture round
1 employees
Biotechnology, Health Care
Sola Diagnostics GmbH vs

Improving health through innovative tests that guide patient care

Post-IPO Equity
744 employees
Biotechnology, Health Care

FAQ About Sola Diagnostics GmbH

The WIDยฎ-easy Test - Now also available in Switzerland ๐Ÿ‡จ๐Ÿ‡ญ ๐Ÿ‘‰ Unnecessary hysteroscopy and curettage can be avoided
Sola Diagnostics GmbH was founded in 2020.
Sola Diagnostics GmbH is headquartered in Austria.
Sola Diagnostics GmbH operates in Biotechnology and Health Care. Its work centres on women's health diagnostics, epigenetic testing, gynecological diagnostics and DNA methylation. Its customers include Patients, healthcare providers and and laboratories.
Sola Diagnostics GmbH has approximately 2 employees.
Sola Diagnostics GmbH has completed 5 funding rounds, raising a total of $2.39M. The latest funding stage is Seed.
Sola Diagnostics GmbH offers: Developing and providing epigenetic diagnostic tests for gynecological cancer detection.
Top alternatives and competitors to Sola Diagnostics GmbH include Antegenes, Clear Genetics (YC W17, acquired by Invitae), Castle Biosciences, Inc., Cleveland Diagnostics, PRECIVA INCORPORATED. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sola Diagnostics GmbH and Antegenes are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sola Diagnostics GmbH, https://bouncewatch.com/company/sola-diagnostics, updated 13 April 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout